BioCatch appoints Gadi Mazor as CEO alongside Howard Edelstein remaining as Board Chairman

– ISRAEL, Tel Aviv-Yafo –  BioCatch, the market leader in behavioral biometrics, today announced the appointment of Gadi Mazor as CEO, succeeding Howard Edelstein who will step down as CEO but continue as Chairman of the Board of Directors.

Howard Edelstein will continue to partner with key customers and the company’s Client Innovation Board and related strategic initiatives, returning to a role similar to the one held prior to assuming the CEO position.

“BioCatch has advanced our technical leadership position and accelerated our global growth trajectory thanks to the hard work and commitment of our team and our ability to execute with the backing of our investors,” “Gadi is a tremendous innovator and driver of change, and he brings an exceptional set of skills and entrepreneurial vision to BioCatch for our next stages of growth and innovation. I am really proud of him and thrilled that he will continue with a seamless transition of leadership and keen to continue working with him.” said Board Chairman, Howard Edelstein. 

About Gadi Mazor

During his four-year tenure as COO at BioCatch, Gadi Mazor has worked hand-in-hand with Howard Edelstein to accelerate the company’s global growth, consolidate its position as the leader in behavioral biometrics, and scale BioCatch’s technology, delivery, and operations teams. Gadi Mazor is a highly accomplished founder and CEO of several SaaS companies in the fields of character and voice recognition and wireless communications, including Shonut Ltd., Onset Technology and Nobex Technologies. In 2012, he co-founded OurCrowd, the leading global equity crowdfunding platform, where he served as General Partner and CTO.

“I’ve been fortunate to have had a front row seat to watch BioCatch’s platform protect consumers and organizations of all sizes from some of the greatest digital threats to date” commented Gadi Mazor. “Howard has been an incredible mentor to me and our team, and he will continue to be an invaluable asset to BioCatch and our investors and customers as Chairman as we continue to experience rapid adoption. Criminals are tireless. They are constantly innovating new methods of online fraud and scams, and BioCatch’s category-defining behavioral biometrics technology continues to stay multiple steps ahead of them with the use of machine learning to analyze millions of different behavioral points simultaneously to combat fraud and identity theft. We remain focused on our customers and will continue to power their clients’ secure and seamless digital experiences.”

Gadi Mazor is an innovative and visionary technology executive, who also holds patents on various advancements of wireless communications. He is a veteran of the Israel Defense Forces’ prestigious 8200 unit, completing the officers’ course with extreme honors. He received a B.Sc. and M.Sc. in Mathematics and Probability magna cum laude through the Addi Lautman Interdisciplinary Program for Fostering Excellence at the Tel Aviv University.

About BioCatch

BioCatch is the leader in behavioral biometrics which analyzes an online user’s physical and cognitive digital behavior to protect individuals and their assets. Our mission is to unlock the power of behavior and deliver actionable insights to create a digital world where identity, trust and ease seamlessly co-exist. Leading financial institutions around the globe use BioCatch to more effectively fight fraud, drive digital transformation and accelerate business growth. With over a decade of analyzing data, over 60 patents and unparalleled experience, BioCatch continues to innovate to solve tomorrow’s problems.

For more information :

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.